Table 1.

SARS-CoV-2 vaccines and properties of vaccines.

Vaccine	Efficacy	Type	Storage	Doses
Pfizer–BioNTech [8]	95%	mRNA	−70 °C	2
Moderna [9]	94%	mRNA	−20 °C	2
SputnikV [10]	91%	Viral vector	<=−18 °C	2
AstraZeneca [9]	70%	Viral vector	2–8 °C	2
Convidecia [11]	66%	Viral vector	2–8 °C	1
Janssen [12]	76.7–85.4%	Viral vector	2–8 °C	1
CoviVac [12]	–	Inactivate	2–8 °C	2
Sinopharm [13]	79%	Inactivate	2–8 °C	2
CoronaVac/Sinovac [12]	50%–91%	Inactivate	2–8 °C	2
Covaxin [12]	81%	Inactivate	2–8 °C	2
EpiVacCorona [12]	100%	Protein	2–8 °C	2
ZF2001/RBD-Dimer [14]	70%–95%	Protein	2–8 °C	3
Novavax [15]	89%	Protein	2–8 °C	2